Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Polynovo ( (AU:PNV) ) has provided an announcement.
Polynovo Limited has announced a change in the director’s interest, with David Williams acquiring an additional 55,000 ordinary shares through Moggs Creek Pty Ltd, a related entity. This acquisition, valued at $87,997.91, increases his total holdings to 21,655,000 shares, reflecting confidence in the company’s market position and potential growth, which may positively impact stakeholders’ perception.
The most recent analyst rating on (AU:PNV) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.
More about Polynovo
Polynovo Limited operates in the medical technology industry, primarily focusing on the development and commercialization of innovative wound care solutions. The company is known for its NovoSorb technology, which is used in a range of products designed to improve healing outcomes for patients with complex wounds.
YTD Price Performance: -23.04%
Average Trading Volume: 3,236,315
Technical Sentiment Signal: Buy
Current Market Cap: A$1.08B
For detailed information about PNV stock, go to TipRanks’ Stock Analysis page.